JACC:主动脉瓣重度狭窄只能换瓣吗?来看看这些影响因素!

2021-11-28 MedSci原创 MedSci原创

每5名严重症状的AS患者中就有1名决定不进行干预,这种决定尤其与年龄大和合并疾病有关。

动脉瓣位于左心室和主动脉之间的开口内。主动脉瓣随左心室收缩而开放,以将血液泵入主动脉。如果某种疾病导致瓣叶增厚、僵硬,瓣膜开口会变窄(狭窄)。有时僵硬的瓣膜也不能完全闭合,左心室每次舒张时,主动脉中的血液会通过主动脉瓣漏回心脏(主动脉瓣反流)。

主动脉瓣狭窄时,左心室为了通过狭窄的瓣膜开口将血液泵入主动脉而不得不更加努力地工作,因此左心室的肌肉壁通常会变厚。增厚的心肌需要冠状动脉供应更多的血液,但有时(尤其运动时)血供不能满足心肌的需求。血供不足可导致胸闷、晕厥,有时甚至猝死。心肌也逐渐衰弱,导致心力衰竭。

目前,手术是主动脉瓣狭窄的唯一治疗方法,但指南和实践之间存在着差距。及其,来自法国的研究人员分析了EORP VHDII调查中对严重主动脉瓣狭窄患者进行干预的决定。结果发表在JACC杂志上。

研究人员在2152名严重主动脉瓣患者中,纳入1271名有症状的高梯度主动脉瓣狭窄患者。主要终点是干预的决定。

262名患者(20.6%)作出了不干预的决定。在多变量分析中,决定不干预与年龄较大(每增加10岁,OR=1.34;95%CI:1.11-1.61)、NYHA 分级更低(OR=1.63;95%CI:1. 16-2.30),年龄调整后的Charlson合并症指数较高(OR=1.09;95% CI:1.01-1.17),经主动脉平均梯度较低(每减少10毫米汞柱,OR=0.81;95% CI:0.71-0.92)。

重度症状性主动脉瓣狭窄的当代管理方法

在研究期间,346名患者(40.2%,中位年龄84岁,中位EuroSCORE II(3.1%)接受了经导管干预,515名患者(59.8%,中位年龄69岁,中位EuroSCORE II 1.5%)接受了手术。与选择干预的患者相比,不干预的决定与较低的6个月生存率有关(87.4%;95%CI:82.0-91.3 vs 94.6%;95%CI:92.8-95.9)。

综上,尽管有一级干预建议,但每5名严重症状的AS患者中就有1名决定不进行干预,这种决定尤其与年龄大和合并疾病有关。

 

参考文献:

Contemporary Management of Severe Symptomatic Aortic Stenosis. J Am Coll Cardiol. 2021 Nov, 78 (22) 2131–2143

评论区 (5)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1855023, encodeId=960a18550230f, content=<a href='/topic/show?id=48351020537' target=_blank style='color:#2F92EE;'>#JACC#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=101, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=10205, encryptionId=48351020537, topicName=JACC)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=55ce62, createdName=hbwxf, createdTime=Sat Jul 23 21:05:14 CST 2022, time=2022-07-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1326895, encodeId=d51b132689520, content=<a href='/topic/show?id=96c71804b7' target=_blank style='color:#2F92EE;'>#ACC#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=97, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=1804, encryptionId=96c71804b7, topicName=ACC)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1e452500029, createdName=12498568m50暂无昵称, createdTime=Tue Nov 30 01:05:14 CST 2021, time=2021-11-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1332817, encodeId=e3d3133281e85, content=<a href='/topic/show?id=1dd6231822d' target=_blank style='color:#2F92EE;'>#主动脉瓣#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=102, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=23182, encryptionId=1dd6231822d, topicName=主动脉瓣)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=dc4b2500077, createdName=hittouch, createdTime=Tue Nov 30 01:05:14 CST 2021, time=2021-11-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1415793, encodeId=57211415e93a6, content=<a href='/topic/show?id=04812314540' target=_blank style='color:#2F92EE;'>#主动脉#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=88, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=23145, encryptionId=04812314540, topicName=主动脉)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=77603112682, createdName=circumcision, createdTime=Tue Nov 30 01:05:14 CST 2021, time=2021-11-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1465618, encodeId=c63314656185d, content=<a href='/topic/show?id=144f5032688' target=_blank style='color:#2F92EE;'>#影响因素#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=100, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=50326, encryptionId=144f5032688, topicName=影响因素)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=80a06745918, createdName=chenzhuanggui, createdTime=Tue Nov 30 01:05:14 CST 2021, time=2021-11-30, status=1, ipAttribution=)]
    2022-07-23 hbwxf
  2. [GetPortalCommentsPageByObjectIdResponse(id=1855023, encodeId=960a18550230f, content=<a href='/topic/show?id=48351020537' target=_blank style='color:#2F92EE;'>#JACC#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=101, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=10205, encryptionId=48351020537, topicName=JACC)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=55ce62, createdName=hbwxf, createdTime=Sat Jul 23 21:05:14 CST 2022, time=2022-07-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1326895, encodeId=d51b132689520, content=<a href='/topic/show?id=96c71804b7' target=_blank style='color:#2F92EE;'>#ACC#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=97, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=1804, encryptionId=96c71804b7, topicName=ACC)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1e452500029, createdName=12498568m50暂无昵称, createdTime=Tue Nov 30 01:05:14 CST 2021, time=2021-11-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1332817, encodeId=e3d3133281e85, content=<a href='/topic/show?id=1dd6231822d' target=_blank style='color:#2F92EE;'>#主动脉瓣#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=102, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=23182, encryptionId=1dd6231822d, topicName=主动脉瓣)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=dc4b2500077, createdName=hittouch, createdTime=Tue Nov 30 01:05:14 CST 2021, time=2021-11-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1415793, encodeId=57211415e93a6, content=<a href='/topic/show?id=04812314540' target=_blank style='color:#2F92EE;'>#主动脉#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=88, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=23145, encryptionId=04812314540, topicName=主动脉)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=77603112682, createdName=circumcision, createdTime=Tue Nov 30 01:05:14 CST 2021, time=2021-11-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1465618, encodeId=c63314656185d, content=<a href='/topic/show?id=144f5032688' target=_blank style='color:#2F92EE;'>#影响因素#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=100, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=50326, encryptionId=144f5032688, topicName=影响因素)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=80a06745918, createdName=chenzhuanggui, createdTime=Tue Nov 30 01:05:14 CST 2021, time=2021-11-30, status=1, ipAttribution=)]
  3. [GetPortalCommentsPageByObjectIdResponse(id=1855023, encodeId=960a18550230f, content=<a href='/topic/show?id=48351020537' target=_blank style='color:#2F92EE;'>#JACC#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=101, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=10205, encryptionId=48351020537, topicName=JACC)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=55ce62, createdName=hbwxf, createdTime=Sat Jul 23 21:05:14 CST 2022, time=2022-07-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1326895, encodeId=d51b132689520, content=<a href='/topic/show?id=96c71804b7' target=_blank style='color:#2F92EE;'>#ACC#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=97, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=1804, encryptionId=96c71804b7, topicName=ACC)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1e452500029, createdName=12498568m50暂无昵称, createdTime=Tue Nov 30 01:05:14 CST 2021, time=2021-11-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1332817, encodeId=e3d3133281e85, content=<a href='/topic/show?id=1dd6231822d' target=_blank style='color:#2F92EE;'>#主动脉瓣#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=102, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=23182, encryptionId=1dd6231822d, topicName=主动脉瓣)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=dc4b2500077, createdName=hittouch, createdTime=Tue Nov 30 01:05:14 CST 2021, time=2021-11-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1415793, encodeId=57211415e93a6, content=<a href='/topic/show?id=04812314540' target=_blank style='color:#2F92EE;'>#主动脉#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=88, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=23145, encryptionId=04812314540, topicName=主动脉)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=77603112682, createdName=circumcision, createdTime=Tue Nov 30 01:05:14 CST 2021, time=2021-11-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1465618, encodeId=c63314656185d, content=<a href='/topic/show?id=144f5032688' target=_blank style='color:#2F92EE;'>#影响因素#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=100, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=50326, encryptionId=144f5032688, topicName=影响因素)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=80a06745918, createdName=chenzhuanggui, createdTime=Tue Nov 30 01:05:14 CST 2021, time=2021-11-30, status=1, ipAttribution=)]
  4. [GetPortalCommentsPageByObjectIdResponse(id=1855023, encodeId=960a18550230f, content=<a href='/topic/show?id=48351020537' target=_blank style='color:#2F92EE;'>#JACC#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=101, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=10205, encryptionId=48351020537, topicName=JACC)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=55ce62, createdName=hbwxf, createdTime=Sat Jul 23 21:05:14 CST 2022, time=2022-07-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1326895, encodeId=d51b132689520, content=<a href='/topic/show?id=96c71804b7' target=_blank style='color:#2F92EE;'>#ACC#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=97, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=1804, encryptionId=96c71804b7, topicName=ACC)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1e452500029, createdName=12498568m50暂无昵称, createdTime=Tue Nov 30 01:05:14 CST 2021, time=2021-11-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1332817, encodeId=e3d3133281e85, content=<a href='/topic/show?id=1dd6231822d' target=_blank style='color:#2F92EE;'>#主动脉瓣#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=102, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=23182, encryptionId=1dd6231822d, topicName=主动脉瓣)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=dc4b2500077, createdName=hittouch, createdTime=Tue Nov 30 01:05:14 CST 2021, time=2021-11-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1415793, encodeId=57211415e93a6, content=<a href='/topic/show?id=04812314540' target=_blank style='color:#2F92EE;'>#主动脉#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=88, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=23145, encryptionId=04812314540, topicName=主动脉)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=77603112682, createdName=circumcision, createdTime=Tue Nov 30 01:05:14 CST 2021, time=2021-11-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1465618, encodeId=c63314656185d, content=<a href='/topic/show?id=144f5032688' target=_blank style='color:#2F92EE;'>#影响因素#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=100, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=50326, encryptionId=144f5032688, topicName=影响因素)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=80a06745918, createdName=chenzhuanggui, createdTime=Tue Nov 30 01:05:14 CST 2021, time=2021-11-30, status=1, ipAttribution=)]
  5. [GetPortalCommentsPageByObjectIdResponse(id=1855023, encodeId=960a18550230f, content=<a href='/topic/show?id=48351020537' target=_blank style='color:#2F92EE;'>#JACC#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=101, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=10205, encryptionId=48351020537, topicName=JACC)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=55ce62, createdName=hbwxf, createdTime=Sat Jul 23 21:05:14 CST 2022, time=2022-07-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1326895, encodeId=d51b132689520, content=<a href='/topic/show?id=96c71804b7' target=_blank style='color:#2F92EE;'>#ACC#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=97, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=1804, encryptionId=96c71804b7, topicName=ACC)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1e452500029, createdName=12498568m50暂无昵称, createdTime=Tue Nov 30 01:05:14 CST 2021, time=2021-11-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1332817, encodeId=e3d3133281e85, content=<a href='/topic/show?id=1dd6231822d' target=_blank style='color:#2F92EE;'>#主动脉瓣#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=102, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=23182, encryptionId=1dd6231822d, topicName=主动脉瓣)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=dc4b2500077, createdName=hittouch, createdTime=Tue Nov 30 01:05:14 CST 2021, time=2021-11-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1415793, encodeId=57211415e93a6, content=<a href='/topic/show?id=04812314540' target=_blank style='color:#2F92EE;'>#主动脉#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=88, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=23145, encryptionId=04812314540, topicName=主动脉)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=77603112682, createdName=circumcision, createdTime=Tue Nov 30 01:05:14 CST 2021, time=2021-11-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1465618, encodeId=c63314656185d, content=<a href='/topic/show?id=144f5032688' target=_blank style='color:#2F92EE;'>#影响因素#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=100, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=50326, encryptionId=144f5032688, topicName=影响因素)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=80a06745918, createdName=chenzhuanggui, createdTime=Tue Nov 30 01:05:14 CST 2021, time=2021-11-30, status=1, ipAttribution=)]

相关资讯

Eur Heart J:经导管主动脉瓣植入中新一代自扩张瓣膜vs.球囊扩张瓣膜的比较:随机SOLVE-TAVI试验

在接受经股动脉TAVI的主动脉瓣狭窄患者中,新一代SEV与BEV的主要瓣膜相关疗效终点相当。

Eur Heart J:甘油三酯和残留胆固醇与主动脉瓣狭窄的风险相关

甘油三酯和残留胆固醇较高在观察和遗传学上与主动脉瓣狭窄的风险升高有关。

Circulation:经手术与经导管主动脉瓣置换术术后1年的心超检查对比

本研究旨在比较低风险的重度主动脉狭窄患者经手术主动脉瓣置换术(SAVR)或经导管主动脉瓣置换术(TAVR)后的超声心动图表现。

Diabetologia:糖尿病合并主动脉狭窄与NF-κB表达增加以及更明显的瓣膜钙化有关

主动脉瓣狭窄(AS)是一种进行性疾病,与主动脉瓣口减少和由于钙积聚而导致的小叶活动减少有关。

Heart:**阶段射血分数在主动脉狭窄中的决定因素和预后价值

EF1可量化主动脉瓣狭窄的早期、潜在可逆性收缩功能障碍,与总体后负荷和心肌纤维化有关,并且是AVR的独立预测因素。

Heart:严重主动脉瓣狭窄患者主动脉瓣置换后的左心室充盈压和生存率

接受AVR的AS患者术前左心室充盈压升高是常见现象,无论其症状如何,均具有重要的预后意义。

拓展阅读

TAVR:心脏治疗新趋势与挑战全解析

TAVR 作为主动脉狭窄的创新疗法,应用广泛且成功率提升,但术后中风、传导阻滞等并发症需关注。高血压、房颤等是风险因素,现有预防措施如 Sentinel 系统,未来需优化器械与机制研究。

Heart:血糖异常与主动脉狭窄之间的关系

随着人口的老龄化,主动脉瓣狭窄的患病率预计会增加。血糖异常,包括血糖水平低于糖尿病范围,与较高的主动脉狭窄风险相关。

JAHA:主动脉狭窄患者管理的临床结局

在5年的随访中,只有三分之二的严重AS患者进行了AVR。未经治疗的严重AS患者死亡率高,主要是AVR下降的心血管疾病患者。

Circulation:二尖瓣和三尖瓣主动脉狭窄患者主动脉瓣置换术后的传导障碍和预后情况

SAVR后新发LBBB与全因死亡率增加相关,并且与TAV-AS患者相比,BAV-AS患者更常见的并发症。

JAHA:女性体重指数与主动脉狭窄风险的关系

退行性主动脉瓣狭窄(AS)的患病率随着年龄的增长而增加。在女性中,BMI增加与AS风险升高一致且独立相关。

JAHA:主动脉狭窄患者心肌血流储备、冠脉微血管健康和心肌重构

随着AS严重程度的增加,MFR下降,GLS恶化,这反映了冠状动脉微血管健康状况和心肌重构恶化。正电子发射断层扫描衍生的MFR与左室射血分数和GLS有显著的独立相关性。